Drug

Dicobalt edetate

As of the edition of 20 October 2026, Dicobalt edetate is a small molecule: marketed.

Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.

The drug

Status
Marketed
Kind
Small molecule
Brand name
Kelocyanor
Approvals on record
1 in 1 region
Holder of the most recent approval
Serb

US protection

No US approval on record.

With no US approval on record there are no listed US patents or exclusivities.

This is the US only.